Pulmonx Corp LUNG:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
8.91UNCH (UNCH)
Volume
15,081
Close
8.91quote price arrow up+0.14 (+1.60%)
Volume
186,200
52 week range
7.11 - 14.84
Loading...
  • Open8.87
  • Day High9.20
  • Day Low8.73
  • Prev Close8.77
  • 52 Week High14.84
  • 52 Week High Date02/15/24
  • 52 Week Low7.11
  • 52 Week Low Date04/25/24

Key Stats

  • Market Cap345.848M
  • Shares Out38.82M
  • 10 Day Average Volume0.68M
  • Dividend-
  • Dividend Yield-
  • Beta0.70
  • YTD % Change-30.12

KEY STATS

  • Open8.87
  • Day High9.20
  • Day Low8.73
  • Prev Close8.77
  • 52 Week High14.84
  • 52 Week High Date02/15/24
  • 52 Week Low7.11
  • 52 Week Low Date04/25/24
  • Market Cap345.848M
  • Shares Out38.82M
  • 10 Day Average Volume0.68M
  • Dividend-
  • Dividend Yield-
  • Beta0.70
  • YTD % Change-30.12

RATIOS/PROFITABILITY

  • EPS (TTM)-1.54
  • P/E (TTM)-5.80
  • Fwd P/E (NTM)-5.02
  • EBITDA (TTM)-58.523M
  • ROE (TTM)-46.17%
  • Revenue (TTM)72.994M
  • Gross Margin (TTM)74.31%
  • Net Margin (TTM)-80.46%
  • Debt To Equity (MRQ)33.70%

EVENTS

  • Earnings Date07/31/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pulmonx Corp

 

Profile

MORE
Pulmonx Corporation is a commercial-stage medical technology company. The Company provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. Its solutions, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform (StratX Platform), is designed to treat severe emphysema patients. The StratX Platform is a...
Dana Mead Jr.
Independent Chairman of Board
Steven Williamson
President, Chief Executive Officer, Director
Mehul Joshi
Chief Financial Officer, Principal Financial and Chief Accounting Officer
David Lehman
General Counsel
Address
700 Chesapeake Dr
Redwood City, CA
94063
United States

Top Peers

SYMBOLLASTCHG%CHG
NPCE
Neuropace Inc
8.51-0.01-0.12%
SGHT
Sight Sciences Inc
5.45+0.03+0.55%
BFLY
Butterfly Network Inc
0.9829+0.0278+2.9107%
SMLR
Semler Scientific Inc
23.50+0.41+1.80%
AKYA
Akoya Biosciences Inc
2.90-1.22-29.61%